PL3097188T3 - Przetwarzanie końcowe fosfatazy alkalicznej - Google Patents
Przetwarzanie końcowe fosfatazy alkalicznejInfo
- Publication number
- PL3097188T3 PL3097188T3 PL15703640T PL15703640T PL3097188T3 PL 3097188 T3 PL3097188 T3 PL 3097188T3 PL 15703640 T PL15703640 T PL 15703640T PL 15703640 T PL15703640 T PL 15703640T PL 3097188 T3 PL3097188 T3 PL 3097188T3
- Authority
- PL
- Poland
- Prior art keywords
- alkaline phosphatase
- downstream processing
- downstream
- processing
- phosphatase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03001—Alkaline phosphatase (3.1.3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14152542 | 2014-01-24 | ||
| EP15703640.1A EP3097188B1 (en) | 2014-01-24 | 2015-01-26 | Downstream processing of an alkaline phosphatase |
| PCT/NL2015/050046 WO2015112015A1 (en) | 2014-01-24 | 2015-01-26 | Downstream processing of an alkaline phosphatase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3097188T3 true PL3097188T3 (pl) | 2018-11-30 |
Family
ID=49989634
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15703640T PL3097188T3 (pl) | 2014-01-24 | 2015-01-26 | Przetwarzanie końcowe fosfatazy alkalicznej |
| PL18190484T PL3461891T3 (pl) | 2014-01-24 | 2015-01-26 | Przetwarzanie końcowe fosfatazy alkalicznej |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18190484T PL3461891T3 (pl) | 2014-01-24 | 2015-01-26 | Przetwarzanie końcowe fosfatazy alkalicznej |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10570380B2 (pl) |
| EP (2) | EP3461891B1 (pl) |
| JP (3) | JP6713147B2 (pl) |
| CN (3) | CN106459143A (pl) |
| CA (1) | CA2936829C (pl) |
| DK (2) | DK3097188T3 (pl) |
| ES (2) | ES2810813T3 (pl) |
| HU (2) | HUE040230T2 (pl) |
| PL (2) | PL3097188T3 (pl) |
| PT (1) | PT3461891T (pl) |
| SI (2) | SI3097188T1 (pl) |
| WO (1) | WO2015112015A1 (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2887039T3 (es) | 2004-04-21 | 2021-12-21 | Alexion Pharma Inc | Conjugados para administración ósea y procedimiento de uso de estos para dirigir proteínas al hueso |
| JP6940949B2 (ja) | 2014-01-24 | 2021-09-29 | アーエム−ファルマ ベー．フェー．ＡＭ−Ｐｈａｒｍａ Ｂ．Ｖ． | キメラアルカリホスファターゼ様タンパク質 |
| US10822596B2 (en) | 2014-07-11 | 2020-11-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for treating craniosynostosis |
| WO2016090251A1 (en) | 2014-12-05 | 2016-06-09 | Alexion Pharmaceuticals, Inc. | Treating seizure with recombinant alkaline phosphatase |
| EP3250227A2 (en) | 2015-01-28 | 2017-12-06 | Alexion Pharmaceuticals, Inc. | Methods of treating a subject with an alkaline phosphatase deficiency |
| MX2018002121A (es) | 2015-08-17 | 2018-06-18 | Alexion Pharma Inc | Elaboracion de fosfatasas alcalinas. |
| US11229686B2 (en) | 2015-09-28 | 2022-01-25 | Alexion Pharmaceuticals, Inc. | Reduced frequency dosage regimens for tissue non-specific alkaline phosphatase (TNSALP)-enzyme replacement therapy of hypophosphatasia |
| JP2018533571A (ja) | 2015-10-30 | 2018-11-15 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 患者の頭蓋縫合早期癒合症を治療するための方法 |
| EP3426286A4 (en) | 2016-03-08 | 2019-12-04 | Alexion Pharmaceuticals, Inc. | METHODS OF TREATING HYPOPHOSPHATASE IN CHILDREN |
| EP3436020A4 (en) | 2016-04-01 | 2019-12-25 | Alexion Pharmaceuticals, Inc. | METHOD FOR TREATING HYPOPHOSPHATASIE IN TEENS AND ADULTS |
| JP2019513711A (ja) | 2016-04-01 | 2019-05-30 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | アルカリホスファターゼによって筋力低下を治療すること |
| US10988744B2 (en) | 2016-06-06 | 2021-04-27 | Alexion Pharmaceuticals, Inc. | Method of producing alkaline phosphatase |
| US11116821B2 (en) | 2016-08-18 | 2021-09-14 | Alexion Pharmaceuticals, Inc. | Methods for treating tracheobronchomalacia |
| EP3600383A4 (en) | 2017-03-31 | 2020-10-28 | Alexion Pharmaceuticals, Inc. | METHODS FOR TREATMENT OF HYPOPHOSPHATASIA (HPP) IN ADULTS AND ADOLESCENTS |
| CA3087569A1 (en) | 2018-01-09 | 2019-07-18 | Synthetic Biologics, Inc. | Alkaline phosphatase agents for treatment of neurodevelopmental disorders |
| EP3773686B1 (en) | 2018-03-20 | 2023-06-07 | Theriva Biologics, Inc. | Alkaline phosphatase agents for treatment of radiation disorders |
| CA3094173A1 (en) | 2018-03-20 | 2019-09-26 | Synthetic Biologics, Inc. | Intestinal alkaline phosphatase formulations |
| WO2019190752A1 (en) | 2018-03-30 | 2019-10-03 | Alexion Pharmaceuticals, Inc. | Manufacturing of glycoproteins |
| WO2020243697A1 (en) | 2019-05-31 | 2020-12-03 | Rhogen Biotech Llc | Compositions and methods for detoxifying bacterial endotoxins |
| AU2021364779A1 (en) * | 2020-10-23 | 2023-06-01 | Alexion Pharmaceuticals, Inc. | Method of controlling total sialic acid content (tsac) during manufacturing of alkaline phosphatase |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8328918D0 (en) * | 1983-10-28 | 1983-11-30 | Unilever Plc | Alkaline phosphatase |
| ES2106737T3 (es) | 1990-02-07 | 1997-11-16 | Abbott Lab | Enzimas de fosfatasa alcalina con actividad especifica mejorada para uso en reactivos indicadores. |
| DK0584343T3 (da) | 1992-03-10 | 1999-09-13 | Jolla Cancer Res Found | Rekombinant alkalisk phosphatase fra kalvetarme |
| WO1994027603A1 (en) | 1993-06-01 | 1994-12-08 | Cortex Pharmaceuticals, Inc. | Alkaline and acid phosphatase inhibitors in treatment of neurological disorders |
| WO1995005455A1 (en) | 1993-08-13 | 1995-02-23 | Rijksuniversiteit Te Groningen | Pharmaceutical composition comprising phosphatase or a derivative thereof |
| WO1995013824A1 (en) | 1993-11-15 | 1995-05-26 | Celtrix Pharmaceuticals, Inc. | Method of treating renal disease by administering igf-i and igfbp-3 |
| US20020055098A1 (en) * | 1994-04-18 | 2002-05-09 | Joseph Szasz | Thermostable alkaline phosphatases |
| JP3625503B2 (ja) * | 1994-11-11 | 2005-03-02 | 旭化成ファーマ株式会社 | 臨床検査用複合酵素含有組成物 |
| JP4035738B2 (ja) * | 1995-01-12 | 2008-01-23 | 東洋紡績株式会社 | 新規なアルカリホスファターゼ |
| CA2222626A1 (en) | 1995-06-06 | 1996-12-12 | Biocoll Laboratories, Inc. | Modified osteogenic materials |
| FR2736065B1 (fr) | 1995-06-29 | 1997-09-19 | Commissariat Energie Atomique | Phosphatases alcalines bacteriennes modifiees et leurs applications. |
| CA2188727C (en) * | 1995-10-27 | 2007-12-18 | Joseph Szasz | Thermostable alkaline phosphatase of rhodothermus marinus |
| JP3488327B2 (ja) | 1995-12-21 | 2004-01-19 | よつ葉乳業株式会社 | 牛乳脂肪球膜含有画分の製造法 |
| US20020114802A1 (en) | 1998-02-10 | 2002-08-22 | Tjellstrom Bo Arthur Einar | Oral immunoglobulin treatment for inflammatory bowel disease |
| DE19819962A1 (de) | 1998-05-05 | 1999-11-11 | Roche Diagnostics Gmbh | Hochaktive alkalische Phosphatase |
| AU764247B2 (en) | 1998-12-21 | 2003-08-14 | Pharmaaware Ip B.V. | Diagnosis of sepsis using the LPS-binding moiety of alkaline phosphatase |
| JP2000350596A (ja) | 1999-06-11 | 2000-12-19 | Toyobo Co Ltd | 分泌性アルカリフォスファターゼの選択的活性測定方法 |
| DK1132086T3 (da) | 2000-01-31 | 2006-08-28 | Pfizer Prod Inc | Anvendelse af prostaglandin (PGE2) selektive receptor 4 (EP4) agonister til behandling af akut og kronisk nyresvigt |
| EP1306367B1 (en) | 2000-07-19 | 2007-07-18 | Mitsubishi Pharma Corporation | Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| EP1191097A1 (en) | 2000-09-21 | 2002-03-27 | Leids Universitair Medisch Centrum | Induction of exon skipping in eukaryotic cells |
| DE10101793A1 (de) | 2001-01-17 | 2002-08-01 | Manfred Nilius | Verwendung von SLPI zur Behandlung chronisch-entzündlicher Darmerkrankungen |
| CA2434362A1 (en) | 2001-01-20 | 2002-07-25 | Cardion Ag | Pluripotent adult stem cells derived from regenerative tissue |
| WO2002098433A1 (fr) | 2001-06-01 | 2002-12-12 | Ajinomoto Co., Inc. | Medicaments pour les maladies intestinales |
| JP3507890B2 (ja) | 2001-06-07 | 2004-03-15 | 大阪大学長 | Ｓｈｅｗａｎｅｌｌａｓｐ．ＳＩＢ１株由来の新規なアルカリフォスファターゼ |
| US7157260B2 (en) | 2001-07-26 | 2007-01-02 | Japan Science & Technology Agency | Nicotianamine synthase and gene encoding the same |
| JP4169966B2 (ja) | 2001-11-14 | 2008-10-22 | 株式会社ヤクルト本社 | 炎症性腸疾患予防治療剤 |
| CN1425766A (zh) | 2001-12-19 | 2003-06-25 | 复旦大学 | 一种多肽——人含碱性磷酸酶活性位点的蛋白－9.24和编码这种多肽的多核苷酸 |
| CA2503621A1 (en) | 2002-11-13 | 2004-05-27 | Genentech, Inc. | Methods and compositions for diagnosing dysplasia |
| US7048914B2 (en) | 2002-12-12 | 2006-05-23 | Zoltan Laboratories | Placental alkaline phosphatase to control diabetes |
| AU2003295264A1 (en) | 2002-12-23 | 2004-07-14 | Rijksuniversiteit Groningen | Modulation of the thioredoxin pathway |
| CA2524255C (en) | 2003-03-21 | 2014-02-11 | Academisch Ziekenhuis Leiden | Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| JP4305071B2 (ja) | 2003-06-30 | 2009-07-29 | 株式会社ニコン | 信号補正方法 |
| JP2005065564A (ja) | 2003-08-22 | 2005-03-17 | Hiroshi Ueda | センサー蛋白質 |
| CA2847517A1 (en) | 2004-02-04 | 2005-08-18 | Pharmaaware Sepsis B.V. | Use of alkaline phosphatase for the detoxification of lps present at mucosal barriers |
| US20110142817A1 (en) | 2004-02-04 | 2011-06-16 | Pharmaaware Sepsis B.V. | Means and method for treating and/or preventing necrotizing enterocolitis |
| CA2599577A1 (en) | 2005-03-04 | 2006-09-14 | Verenium Corporation | Nucleic acids and proteins and methods for making and using them |
| US20070059300A1 (en) | 2005-09-12 | 2007-03-15 | Zoltan Laboratories Llc | Compounds and compositions to control abnormal cell growth |
| EP1965830B1 (en) | 2005-12-28 | 2014-05-14 | Zoltan Laboratories Llc | Use of alkaline phosphatase to maintain healthy tissue mass in mammals |
| US20070280922A1 (en) | 2006-06-06 | 2007-12-06 | Zoltan Kiss Consulting | Combinations of human proteins to enhance viability of stem cells and progenitor cells |
| US7718170B2 (en) | 2006-08-21 | 2010-05-18 | Essential Skincare, Llc | Alkaline phosphatase compositions to reduce skin cancer |
| EP1952823A1 (en) * | 2007-01-30 | 2008-08-06 | AM-Pharma B.V. | The use of alkaline phosphatase in the treatment of reduced renal function |
| WO2008104199A1 (en) | 2007-03-01 | 2008-09-04 | Gelato Corporation N.V. | Use of ecto-phosphatases for the treatment of (acute) myocardial infarction |
| EP1985697A1 (en) * | 2007-04-27 | 2008-10-29 | AM-Pharma B.V. | Modified phosphatases |
| EP2030980A1 (en) | 2007-08-28 | 2009-03-04 | AM-Pharma B.V. | Mutants of lactoferrin |
| WO2009106368A1 (en) * | 2008-02-29 | 2009-09-03 | Gelato Corporation N.V. | Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| CA2723424A1 (en) | 2008-05-19 | 2009-11-26 | Burnham Institute For Medical Research | Intestinal alkaline phosphatase modulators and uses thereof |
| KR101804136B1 (ko) * | 2008-06-24 | 2017-12-04 | 옥타파마 아게 | 응고 인자 ｖｉｉｉ을 정제하는 방법 |
| CA2732438A1 (en) | 2008-08-29 | 2010-03-04 | The General Hospital Corporation | Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase |
| US9453045B2 (en) | 2010-03-30 | 2016-09-27 | Octapharma Ag | Process for the purification of a growth factor protein |
| JP2012196170A (ja) * | 2011-03-22 | 2012-10-18 | Sanyo Chem Ind Ltd | セルラーゼ組成物及びこのセルラーゼ組成物を含有する洗剤組成物 |
| EP2717906B1 (en) | 2011-06-08 | 2017-03-01 | AM-Pharma B.V. | The use of alkaline phosphatase for preserving renal function |
| SG10201606218WA (en) * | 2011-07-29 | 2016-09-29 | Eleven Biotherapeutics Inc | Purified Proteins |
-
2015
- 2015-01-26 JP JP2016548122A patent/JP6713147B2/ja active Active
- 2015-01-26 HU HUE15703640A patent/HUE040230T2/hu unknown
- 2015-01-26 PL PL15703640T patent/PL3097188T3/pl unknown
- 2015-01-26 HU HUE18190484A patent/HUE051470T2/hu unknown
- 2015-01-26 CN CN201580015952.3A patent/CN106459143A/zh active Pending
- 2015-01-26 US US15/113,699 patent/US10570380B2/en active Active
- 2015-01-26 DK DK15703640.1T patent/DK3097188T3/en active
- 2015-01-26 SI SI201530394T patent/SI3097188T1/sl unknown
- 2015-01-26 CN CN202010985277.XA patent/CN112029753A/zh active Pending
- 2015-01-26 ES ES18190484T patent/ES2810813T3/es active Active
- 2015-01-26 EP EP18190484.8A patent/EP3461891B1/en active Active
- 2015-01-26 WO PCT/NL2015/050046 patent/WO2015112015A1/en active Application Filing
- 2015-01-26 EP EP15703640.1A patent/EP3097188B1/en active Active
- 2015-01-26 ES ES15703640.1T patent/ES2688066T3/es active Active
- 2015-01-26 PT PT181904848T patent/PT3461891T/pt unknown
- 2015-01-26 PL PL18190484T patent/PL3461891T3/pl unknown
- 2015-01-26 CA CA2936829A patent/CA2936829C/en active Active
- 2015-01-26 DK DK18190484.8T patent/DK3461891T3/da active
- 2015-01-26 SI SI201531291T patent/SI3461891T1/sl unknown
- 2015-01-26 CN CN202010985092.9A patent/CN112048491A/zh active Pending
-
2019
- 2019-09-04 US US16/560,608 patent/US20200063112A1/en not_active Abandoned
-
2020
- 2020-05-13 JP JP2020084763A patent/JP7039645B2/ja active Active
-
2021
- 2021-09-29 JP JP2021159692A patent/JP7449266B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN106459143A (zh) | 2017-02-22 |
| ES2810813T3 (es) | 2021-03-09 |
| JP2022001061A (ja) | 2022-01-06 |
| WO2015112015A8 (en) | 2016-03-03 |
| JP7449266B2 (ja) | 2024-03-13 |
| DK3097188T3 (en) | 2018-10-08 |
| US20170009217A1 (en) | 2017-01-12 |
| SI3461891T1 (sl) | 2020-09-30 |
| CN112029753A (zh) | 2020-12-04 |
| ES2688066T3 (es) | 2018-10-30 |
| CN112048491A (zh) | 2020-12-08 |
| US20200063112A1 (en) | 2020-02-27 |
| JP7039645B2 (ja) | 2022-03-22 |
| HUE051470T2 (hu) | 2021-03-01 |
| EP3097188A1 (en) | 2016-11-30 |
| PT3461891T (pt) | 2020-07-30 |
| JP2017505613A (ja) | 2017-02-23 |
| EP3461891A1 (en) | 2019-04-03 |
| EP3461891B1 (en) | 2020-07-01 |
| CA2936829A1 (en) | 2015-07-30 |
| WO2015112015A1 (en) | 2015-07-30 |
| JP2020127427A (ja) | 2020-08-27 |
| DK3461891T3 (da) | 2020-08-10 |
| EP3097188B1 (en) | 2018-08-29 |
| US10570380B2 (en) | 2020-02-25 |
| SI3097188T1 (sl) | 2018-10-30 |
| HUE040230T2 (hu) | 2019-02-28 |
| CA2936829C (en) | 2024-05-28 |
| JP6713147B2 (ja) | 2020-06-24 |
| PL3461891T3 (pl) | 2020-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE040230T2 (hu) | Egy alkálikus foszfatáz feldolgozási folyamata | |
| GB2528699B (en) | Image processing | |
| IL250089A0 (en) | Metrology of multiple sampling processes | |
| GB2524249B (en) | Image Processing | |
| GB201404734D0 (en) | Image processing | |
| GB2529705B (en) | Message processing | |
| GB2525637B (en) | Message Processing | |
| GB2533581B (en) | Image processing | |
| GB201519344D0 (en) | Oat processing | |
| HK1255588B (zh) | 處理系統 | |
| EP3158817A4 (en) | Reduced-latency processing of voice-over-lte calls | |
| GB2552406B (en) | Laser processing | |
| GB2527553B (en) | Laser processing | |
| GB201420737D0 (en) | Graphic processing systems | |
| IL246569A0 (en) | Solid forms of tenofovir | |
| SG10201504344VA (en) | Component processing | |
| GB201406165D0 (en) | Call processing | |
| PL3111151T3 (pl) | Sposób działania obrotowego pieca do wytwarzania spoiw hydraulicznych | |
| GB2522904B (en) | Method of making an airdam | |
| GB201521655D0 (en) | Object processing | |
| GB2526663B (en) | Processing of poultry | |
| GB201400932D0 (en) | Location of criticality | |
| GB201402298D0 (en) | Processing of microalgae | |
| GB201521201D0 (en) | Processing of poultry | |
| GB201407167D0 (en) | Processing of biomass |